معرفی
Philip CHENNELL is a researcher at the Institut de Chimie de Clermont-Ferrand (ICCF) affiliated with Université Clermont Auvergne's UFR of Pharmacy. He is an active member of both the Materials for Health (MPS) research team and the Medical Devices and Container/Content Interactions (DMIC2) theme, focusing on critical pharmaceutical stability issues in medical device contexts.
Dr. CHENNELL completed his PhD in 2018 with the thesis "Preparation and characterization of ordered porous polymer surfaces for medical applications" at Université Clermont Auvergne. His academic journey has established him as a specialist in pharmaceutical-material interactions, with expertise spanning polymer science, drug stability testing, and medical device safety.
His research interests focus on drug stability in various delivery systems, particularly examining interactions between medications and container materials. He investigates plasticizer migration from $$\text{PVC}$$ medical devices and its clinical implications, develops novel drug delivery systems including ophthalmic formulations, and studies polymeric carriers for controlled release. His methodological approach uniquely combines experimental pharmaceutical testing with molecular simulations to understand drug-material interactions at fundamental levels. This research addresses practical challenges across hospital pharmacy practice, from infusion systems to compounded preparations.
Dr. CHENNELL's publication record shows consistent productivity through 2025, with recent work emphasizing insulin interactions with plasticized materials, drug delivery mechanisms of biodegradable polymers, and the impact of medical device materials on drug stability. His research demonstrates strong interdisciplinary collaboration between chemists, pharmacists, and clinicians to solve real-world challenges in drug delivery and patient safety.
His scientific contributions include significant studies on:
- Drug adsorption to various medical device materials
- Plasticizer migration from $$\text{PVC}$$ devices and $$\text{DEHP}$$ exposure
- Stability of monoclonal antibodies in infusion systems
- Ophthalmic formulation development with cyclodextrins
- Pediatric medication formulations
- Medical device safety in specialized treatments like CAR-T cell therapy
Dr. CHENNELL maintains extensive collaborations, most notably with Valerie Sautou (36 co-authored publications), Lise Bernard, Nicolas Tokhadze, and Yoann Le Basle. His work bridges pharmaceutical science and clinical practice, directly influencing medication preparation, storage, and delivery protocols across diverse clinical settings including neonatology and oncology.
